Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Pds implant with ranibizumab 100 mg/ml's trials
Portal
Extension Study for the Port Delivery System With Ranibizumab (Portal)
PDS Implant with Ranibizumab 100 mg/mL
Ongoing
Recruiting
Phase 3
Open NCT03683251 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
